Oncometabolite d-2HG alters T cell metabolism to impair CD8 + T cell function

Gain-of-function mutations in isocitrate dehydrogenase (IDH) in human cancers result in the production of d-2-hydroxyglutarate (d-2HG), an oncometabolite that promotes tumorigenesis through epigenetic alterations. The cancer cell-intrinsic effects of d-2HG are well understood, but its tumor cell-non...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science (American Association for the Advancement of Science) 2022-09, Vol.377 (6614), p.1519-1529
Hauptverfasser: Notarangelo, Giulia, Spinelli, Jessica B, Perez, Elizabeth M, Baker, Gregory J, Kurmi, Kiran, Elia, Ilaria, Stopka, Sylwia A, Baquer, Gerard, Lin, Jia-Ren, Golby, Alexandra J, Joshi, Shakchhi, Baron, Heide F, Drijvers, Jefte M, Georgiev, Peter, Ringel, Alison E, Zaganjor, Elma, McBrayer, Samuel K, Sorger, Peter K, Sharpe, Arlene H, Wucherpfennig, Kai W, Santagata, Sandro, Agar, Nathalie Y R, Suvà, Mario L, Haigis, Marcia C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!